Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Glioblastoma Multiforme”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00099060
What this trial is testing

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT04743310
What this trial is testing

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Who this might be right for
Central Nervous System Tumor
John Yu 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03663725
What this trial is testing

Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Who this might be right for
Glioblastoma
Centre Oscar Lambret 486
Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT00074243
What this trial is testing

CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00014443
What this trial is testing

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Rush University Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT01032200
What this trial is testing

Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

Who this might be right for
Brain TumorsNervous System TumorsCognition Disorders+1 more
Wake Forest University Health Sciences 54
Testing effectiveness (Phase 2)Study completedNCT00006093
What this trial is testing

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00006355
What this trial is testing

Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00008086
What this trial is testing

Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Adult Solid Tumor, Protocol Specific
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00085540
What this trial is testing

FR901228 in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00116376
What this trial is testing

Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Novartis Pharmaceuticals 64
Large-scale testing (Phase 3)Looking for participantsNCT07452458
What this trial is testing

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma
NRG Oncology 398
Early research (Phase 1)Study completedNCT00002971
What this trial is testing

O(6)-Benzylguanine in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Study completedNCT00008008
What this trial is testing

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Herbert Irving Comprehensive Cancer Center 40
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Testing effectiveness (Phase 2)Study completedNCT00337207
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 55
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Next Page